CareDx, IncCDNANASDAQ
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-0.36%
↓ 107% below average
Average (39q)
5.36%
Historical baseline
Range
High:48.44%
Low:-16.93%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -0.36% |
| Q2 2025 | -9.14% |
| Q1 2025 | 12.06% |
| Q4 2024 | -5.47% |
| Q3 2024 | -11.21% |
| Q2 2024 | 5.25% |
| Q1 2024 | 2.38% |
| Q4 2023 | -3.81% |
| Q3 2023 | -6.09% |
| Q2 2023 | -16.93% |
| Q1 2023 | 3.34% |
| Q4 2022 | 5.67% |
| Q3 2022 | -1.44% |
| Q2 2022 | 3.44% |
| Q1 2022 | -0.75% |
| Q4 2021 | 13.41% |
| Q3 2021 | 2.12% |
| Q2 2021 | 18.95% |
| Q1 2021 | 20.11% |
| Q4 2020 | 6.82% |
| Q3 2020 | -4.99% |
| Q2 2020 | 31.12% |
| Q1 2020 | 11.93% |
| Q4 2019 | 4.99% |
| Q3 2019 | 11.68% |
| Q2 2019 | 35.91% |
| Q1 2019 | 48.44% |
| Q4 2018 | -2.22% |
| Q3 2018 | 10.64% |
| Q2 2018 | 3.80% |
| Q1 2018 | 11.23% |
| Q4 2017 | 2.33% |
| Q3 2017 | -5.10% |
| Q2 2017 | -5.03% |
| Q1 2017 | 4.09% |
| Q4 2016 | 7.65% |
| Q3 2016 | -6.54% |
| Q2 2016 | -0.76% |
| Q1 2016 | 16.83% |
| Q4 2015 | 0.22% |